Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_assertion description "[Finally, although Galpha subunits are the only components of the heterotrimeric GTP binding proteins which harbor known mutations, beta/gamma subunits should be considered possible targets of genetic alterations as suggested by the frequent presence of beta3 subunit variants in patients with essential hypertension.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_assertion evidence source_evidence_literature NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_assertion SIO_000772 11720871 NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_assertion wasDerivedFrom befree-20140225 NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_assertion wasGeneratedBy ECO_0000203 NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.
- befree-20140225 importedOn "2014-02-25" NP538330.RAN6gXVlPCkXAnj6dqGTCbMiXtUoC-fdJu-qjoEhNC66A130_provenance.